Cantor Fitzgerald, L. P. Uro Gen Pharma Ltd. Transaction History
Cantor Fitzgerald, L. P.
- $4.65 Billion
- Q1 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 95,000 shares of URGN stock, worth $549,100. This represents 0.02% of its overall portfolio holdings.
Number of Shares
95,000
Previous 360,000
73.61%
Holding current value
$549,100
Previous $3.83 Million
72.61%
% of portfolio
0.02%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$25.2 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$22.2 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$18.5 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$13.3 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$12.7 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $131M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...